Resources Contact Us Home
Internalizing anti-CD74 antibodies and methods of use

Image Number 15 for United States Patent #7931903.

The present invention provides humanized, chimeric and human anti-CD74 antibodies, CD74 antibody fusion proteins, immunoconjugates, vaccines and bispecific that bind to CD74, the major histocompatibility complex (MHC) class-II invariant chain, Ii, which is useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies, other malignancies in which the cells are reactive with CD74, and autoimmune diseases, and methods of treatment and diagnosis.

  Recently Added Patents
Voltage regulators with improved wake-up response
Direct connect single layer touch panel
Materials for organic electroluminescent devices containing substituted 10-benzo[c]phenanthrenes
Apparatus and method for information display of portable device
Method for growing group III-nitride crystals in supercritical ammonia using an autoclave
Quinoline compounds and their use for treating viral infection
Preserving privacy of digital communication information
  Randomly Featured Patents
Methods and systems for determining a telecommunications service location using global satellite positioning
Sandal system for athletic activities
Mobile device including a force transfer mechanism
Method and system for processing a text search query in a collection of documents
Optical element retracting mechanism for a retractable photographing lens
Writing instrument
Combined fan housing and hatch cover
Plant support
Targeting location through haptic feedback signals
Hair root volumizing clip